IN8BIO, INC. - INAB

Ownership (Schedule 13D / 13G) · latest 50 filings · Back to all files
Visible: 0
Filed Form Reporting person Percent Shares SEC
Mar 02, 2026 SCHEDULE 13G LYTTON LAURENCE W 9.99% 984,031 View
Mar 02, 2026 SCHEDULE 13G LYTTON-KAMBARA FOUNDATION 9.99% 984,031 View
Feb 17, 2026 SCHEDULE 13G Alyeska Investment Group, L.P. 9.9% 966,381 View
Feb 17, 2026 SCHEDULE 13G Alyeska Fund GP, LLC 9.9% 966,381 View
Feb 17, 2026 SCHEDULE 13G Anand Parekh 9.9% 966,381 View
Jan 02, 2026 SCHEDULE 13D 19.99% 2,024 View
Dec 30, 2025 SCHEDULE 13G 683 Capital Management, LLC 7.86% 770,445 View
Dec 30, 2025 SCHEDULE 13G 683 Capital Partners, LP 7.86% 770,445 View
Dec 30, 2025 SCHEDULE 13G Ari Zweiman 7.86% 770,445 View
Dec 29, 2025 SCHEDULE 13D/A 9.99% View
Dec 22, 2025 SCHEDULE 13G Stonepine Capital Management, LLC 9.9% 1,007,990 View
Dec 22, 2025 SCHEDULE 13G Stonepine Capital, L.P. 9.9% 1,007,990 View
Dec 22, 2025 SCHEDULE 13G Stonepine GP, LLC 9.9% 1,007,990 View
Dec 22, 2025 SCHEDULE 13G Jon M. Plexico 9.9% 1,007,990 View
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G. Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F). Amendments (/A) can repeat the same holder over time, so rows should not be summed. Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.